» Articles » PMID: 26972907

Modulation of Kidney Urea Transporter UT-A3 Activity by Alpha2,6-sialylation

Overview
Journal Pflugers Arch
Specialty Physiology
Date 2016 Mar 15
PMID 26972907
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Two urea transporters, UT-A1 and UT-A3, are expressed in the kidney terminal inner medullary collecting duct (IMCD) and are important for the production of concentrated urine. UT-A1, as the largest isoform of all UT-A urea transporters, has gained much attention and been extensively studied; however, the role and the regulation of UT-A3 are less explored. In this study, we investigated UT-A3 regulation by glycosylation modification. A site-directed mutagenesis verified a single glycosylation site in UT-A3 at Asn279. Loss of the glycosylation reduced forskolin-stimulated UT-A3 cell membrane expression and urea transport activity. UT-A3 has two glycosylation forms, 45 and 65 kDa. Using sugar-specific binding lectins, the UT-A3 glycosylation profile was examined. The 45-kDa form was pulled down by lectin concanavalin A (Con A) and Galant husnivalis lectin (GNL), indicating an immature glycan with a high amount of mannose (Man), whereas the 65-kDa form is a mature glycan composed of acetylglucosamine (GlcNAc) and poly-N-acetyllactosame (poly-LacNAc) that was pulled down by wheat germ agglutinin (WGA) and tomato lectin, respectively. Interestingly, the mature form of UT-A3 glycan contains significant amounts of sialic acid. We explored the enzymes responsible for directing UT-A3 sialylation. Sialyltransferase ST6GalI, but not ST3GalIV, catabolizes UT-A3 α2,6-sialylation. Activation of protein kinase C (PKC) by PDB treatment promoted UT-A3 glycan sialylation and membrane surface expression. The PKC inhibitor chelerythrine blocks ST6GalI-induced UT-A3 sialylation. Increased sialylation by ST6GalI increased UT-A3 protein stability and urea transport activity. Collectively, our study reveals a novel mechanism of UT-A3 regulation by ST6GalI-mediated sialylation modification that may play an important role in kidney urea reabsorption and the urinary concentrating mechanism.

Citing Articles

Mammalian urine concentration: a review of renal medullary architecture and membrane transporters.

Nawata C, Pannabecker T J Comp Physiol B. 2018; 188(6):899-918.

PMID: 29797052 PMC: 6186196. DOI: 10.1007/s00360-018-1164-3.


Urea transport and clinical potential of urearetics.

Klein J, Sands J Curr Opin Nephrol Hypertens. 2016; 25(5):444-51.

PMID: 27367911 PMC: 4974121. DOI: 10.1097/MNH.0000000000000252.

References
1.
Huang H, Yang Y, Eaton D, Sands J, Chen G . The N-terminal 81-aa fragment is critical for UT-A1 urea transporter bioactivity. J Epithel Biol Pharmacol. 2010; 3:34-39. PMC: 2886301. DOI: 10.2174/1875044301003010034. View

2.
Spiro R . Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology. 2002; 12(4):43R-56R. DOI: 10.1093/glycob/12.4.43r. View

3.
Stewart G, Thistlethwaite A, LEES H, Cooper G, Smith C . Vasopressin regulation of the renal UT-A3 urea transporter. Am J Physiol Renal Physiol. 2008; 296(3):F642-8. DOI: 10.1152/ajprenal.90660.2008. View

4.
Klein J, Blount M, Sands J . Urea transport in the kidney. Compr Physiol. 2013; 1(2):699-729. DOI: 10.1002/cphy.c100030. View

5.
Stewart G, Fenton R, Wang W, Kwon T, White S, Collins V . The basolateral expression of mUT-A3 in the mouse kidney. Am J Physiol Renal Physiol. 2004; 286(5):F979-87. DOI: 10.1152/ajprenal.00334.2003. View